Pharmaceutical Contract Manufacturing Market 2017-2027

医薬品受託製造の世界市場2017-2027

◆タイトル:Pharmaceutical Contract Manufacturing Market 2017-2027
◆商品コード:VGAIN702037
◆調査・発行会社:visiongain
◆発行日:2017年2月
◆ページ数:235
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Sigle User(1名閲覧)GBP2,499 ⇒換算¥387,345見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥464,845見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥774,845見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、医薬品受託製造の世界市場について調査・分析し、医薬品受託製造の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
・レポートの概要
・イントロダクション
・医薬品受託製造の世界市場
 (市場規模予測、市場動向、市場の成長要因・阻害要因など)
・医薬品受託製造の世界市場:セグメント別市場分析
・医薬品受託製造の世界市場:地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論

The pharmaceutical contract manufacturing market is expected to grow at a CAGR of 6.4% in the first half of the forecast period and CAGR of 5.7% in the second half of the forecast period. The market is estimated at $88bn in 2021 and $124bn in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 235-page report you will receive 82 tables and 61 figures– all unavailable elsewhere.

The 235-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.


Report Scope
• Global Pharmaceutical Contract Manufacturing Market forecasts from 2017-2027

• Submarket forecasts at world level, from 2017-2027:
- Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products
- Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types
- Other applications of outsourced production - other related services

• Revenue forecasts from 2017-2027, for 12 countries:
- United States (US)
- EU5: Germany, France, the UK, Italy and Spain
- BRIC: Brazil, Russia, India and China
- South Korea
- Japan

• Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry

• Qualitative Analysis from a CMO Perspective 2016-2027

• Qualitative Analysis from a Client Perspective 2016-2027

Visiongain’s study is intended for anyone requiring commercial analyses for the Pharmaceutical Contract Manufacturing Market. You find data, trends and predictions.

Buy our report today Pharmaceutical Contract Manufacturing Market 2017-2027: Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages.

【レポートの目次】

1. Report Overview
1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation
1.2 Global Pharmaceutical Contract Manufacturing Market Overview
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pharmaceutical Contract Manufacturing
2.1 What is Pharmaceutical Contract Manufacturing?
2.2 The Benefits of Outsourcing in the Pharmaceutical Market
2.3 Pharmaceutical Contract Manufacturing Services
2.4 Strategy and Tactics: The Importance of Outsourcing Wisely
2.5 Trends in Contract Manufacturing, 2016-2027
2.6 Pharmaceutical Contract Manufacturing: Market Segmentation

3. Pharmaceutical Contract Manufacturing: World Market 2015-2027
3.1 Pharmaceutical Contract Manufacturing Market: Historical Performance 2012-2016
3.1.1 Contract Manufacturing is the Most Mature Pharma Outsourcing Sector
3.1.2 The Pharma Contract Manufacturing Market by Sector 2016
3.2 Pharma Contract Manufacturing: Overall Market Forecast 2015-2027
3.2.1 Changing Submarket Shares by Segment 2015-2027
3.2.2 Drivers for Growth in the Contract Manufacturing Market to 2027
3.2.3 Generics: A Driver or Restraint?
3.2.4 Other Contract Manufacturing Services Submarket: Outlook and Forecast 2016
3.2.4.1 Increasing Demand for Formulation Development Services

4. The Contract API Manufacturing Services Submarket 2015-2027
4.1 The Contract API Manufacturing Submarket, 2016
4.1.1 Chemical APIs Will Experience Resurgence After the Shift of Focus to Biological APIs
4.1.2 The API Manufacturing Submarket by Sector, 2016
4.2 The Contract API Manufacturing Submarket: Outlook and Forecast 2015-2027
4.2.1 Drivers for Growth in the API Submarket to 2027
4.2.2 The Potential for Microreactors in Commercial Manufacturing to 2027
4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?
4.2.4 Contract API Manufacturing Submarket Restraint 2016-2027
4.2.4.1 Backwards Integration for Generics Manufacturers
4.3 The Contract Generic API Manufacturing Submarket 2015-2027
4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2015-2027
4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2027
4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing
4.4 The Contract HPAPI Manufacturing Submarket 2015-2027
4.4.1 Challenges and Opportunities in High Containment Manufacturing
4.4.2 Company Investment into HPAPI Manufacturing Facilities: Growth Increases in the HPAPI Manufacturing Sector
4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2015-2027
4.4.4 The Contract HPAPI Manufacturing Submarket Drivers and Restraints to 2027

5. The Contract FDF Manufacturing Services Submarket 2015-2027
5.1 The Contract FDF Manufacturing Submarket, 2016
5.1.1 Solid Dosage Manufacturing Leads the Market
5.1.2 CMOs Report High Demand for Softgel Formulations
5.2 The Contract FDF Manufacturing Submarket Forecast 2015-2027
5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2027
5.2.2 What Will Restrain Growth in FDF Outsourcing?
5.3 The Contract Solid Dosage Manufacturing Submarket 2015-2027
5.3.1 How Will Revenue for Solid Dosage Manufacturing Grow to 2027?
5.3.2 The Solid Dosage Manufacturing Submarket Drivers and Restraints 2016-2027
5.3.2.1 Will Product Reformulation Drive Growth to 2027?
5.4 The Contract Injectable Dosage Manufacturing Submarket 2015-2027
5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2015-2027
5.4.1.1 Drug Shortages Offer Opportunity to CMOs in the Short-Term
5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2016-2027
5.4.2.1 Interest in Antibody-Drug Conjugate Development Is Growing
5.4.2.2 Challenges in Manufacturing Antibody-Drug Conjugates
5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise
5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing?

6. Leading National Markets for Pharmaceutical Contract Manufacturing 2015-2027
6.1 Leading National Markets for Pharmaceutical Contract Manufacturing, 2016
6.1.1 Challenges in Assessing the Market: Supply versus Demand
6.1.2 Leading National Pharmaceutical Contract Manufacturing Markets: Revenue Forecasts 2015-2027
6.1.3 Pharmaceutical Manufacturing in the US: Regulatory Oversight 2014-2016
6.1.4 Controlling Foreign Manufacturing Sites
6.1.5 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing?
6.1.6 Outsourcing and US Manufacturing Regulations
6.1.7 Increased Demand for Domestic API Manufacturing?
6.2 The US Contract Manufacturing Market Forecast 2015-2027
6.3 Outlook for Pharmaceutical Contract Manufacturing in the EU
6.3.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing
6.3.2 Regulatory Aspects of Pharma Manufacturing in the EU
6.3.2.1 The European Commission Amends Annex 16
6.3.2.2 The Falsified Medicine Directive: Controlling API Imports
6.3.3 Biopharma Manufacturing Demand Will Rise to 2027
6.3.4 The EU Contract Manufacturing Market Forecast 2015-2027
6.3.5 Germany: The Leading EU Destination for API and FDF Manufacturing
6.3.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2015-2027
6.3.6 CMOs Account for a Third of Manufacturing Sites in France
6.3.6.1 French Pharma Contract Manufacturing Market Forecast 2015-2027
6.3.7 Italy: Strong API Manufacturing Traditions
6.3.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Market 2015-2027
6.3.8 Spain: How Will Demand for Manufacturing Services Grow to 2027?
6.3.9 UK: Pharmaceutical Contract Manufacturing Market Forecast 2015-2027
6.4 Pharma Contract Manufacturing in Japan to 2027
6.4.1 Pharmaceutical Manufacturing Regulations in Japan
6.4.1.1 The Pharmaceutical Affairs Law
6.4.2 Greater API Outsourcing to Drive Japanese Market Growth to 2027 In Spite of Currency Devaluation Weakening the Economy

7. Leading Emerging Markets for Pharmaceutical Contract Manufacturing 2015-2027
7.1 Pharmaceutical Contract Manufacturing in Developing Countries
7.1.1 Outsourcing to Emerging National Markets from Developed Markets
7.1.1.1 Demand Will Increase for Services in India and China
7.1.2 Domestic Demand for Pharmaceutical Contract Manufacturing Services
7.1.3 Pharmaceutical Contract Manufacturing: Leading Emerging National Market Forecasts 2015-2027
7.2 Chinese Demand for Pharma Contract Manufacturing Services 2015-2027
7.2.1 Improved Manufacturing Regulations in China
7.2.1.1 New Regulations for Excipients and Guidance for API Manufacturing 2012-2013
7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China?
7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing
7.2.3 China Pharma Contract Manufacturing Market Forecast 2015-2027
7.3 India: CMOs with Strong Infrastructure and Growing Expertise
7.3.1 Regulatory Outlook for Indian Pharma Manufacturing
7.3.1.1 Stricter Quality Standards to Ensure Compliance with EU Rules
7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market
7.3.3 Demand for Contract Manufacturing in India: Market Forecast 2015-2027
7.4 Brazil: Contract Manufacturing Outlook 2015-2027
7.4.1 Pharmaceutical Manufacturing Regulations in Brazil
7.4.1.1 New Guidelines and Regulations Proposed 2012-2013
7.4.2 Brazil Imports Most of its APIs
7.4.3 Brazil: Pharma Contract Manufacturing Market Forecast 2015-2027
7.5 The Russian Pharma Contract Manufacturing Market 2015-2027
7.5.1 Pharma Manufacturing Regulations in Russia
7.5.1.1 Compliance with GMP in Russia
7.5.2 How Will Demand for Contract Manufacturing Grow in Russia to 2027?
7.6 South Korea: Government Supported Growth
7.6.1 South Korea: Strict GMP Regulations
7.6.2 South Korea: Pharma Contract Manufacturing Market Forecast 2015-2027

8. Leading Companies in the Pharmaceutical Contract Manufacturing Market
8.1 Leading CMOs in the Pharmaceutical Contract Manufacturing Market
8.2 Catalent: Leading CMO
8.2.1 Multiple Expansions and Increased Focus on Biologic Manufacturing
8.3 Lonza: Potential to Lead in ADC Manufacturing
8.3.1 Lonza: Expanding its Capacities to Meet Customer Demand for Biologic Manufacturing
8.4 Evonik Degussa: Specialising in Small Molecules
8.4.1 Developments at Evonik Degussa
8.5 DPx Holdings – DSM and Patheon: Recent Merger Has Strengthened Their Position
8.5.1 Increasing Capacity Tactically and Expanding Worldwide
8.6 Teva: The World’s Largest API Manufacturer
8.6.1 Will Teva Expand into Emerging Markets?
8.7 Boehringer Ingelheim BioXcellence: Boehringer’s Biopharma Manufacturing Division
8.7.1 Adding New Services for Growth
8.8 Famar: A Possible Candidate for Acquisition
8.9 Fareva: A Strategic Shift from Acquisition to Increase in Capacity
8.10 Vetter Pharma: Specialists in Aseptic Filling, Lyophilisation and Siliconisation
8.10.1 Vetter’s Growth: Increasing in Capacity and Market Expansion
8.11 Mylan: A World Leader in Generics Manufacturing

9. Pharmaceutical Contract Manufacturing Industry Trends: Qualitative Analysis from a CMO Perspective 2016-2027
9.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a CMO Perspective 2016-2027
9.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a CMO Perspective 2016-2027
9.3 Pharma Contract Manufacturing Market: STEP Analysis 2016-2027
9.3.1 Social Factors
9.3.2 New Technologies Will Drive Market Growth to 2027
9.3.2.1 Advantages of Single-Use Technologies in Biopharma Manufacturing
9.3.2.2 Green Technology in Contract Manufacturing
9.3.2.3 Drug Delivery Trends and CMOs
9.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation
9.3.2.5 Improving Solubility and Stability for Small Molecules
9.3.2.6 Spray Drying as an Advantageous Alternative to Lyophilisation
9.3.2.7 Hot-Melt Extrusion: A Niche Opportunity
9.3.3 Economic Pressures
9.3.3.1 Developed-Market CMOs Facing Competition from Emerging Markets
9.3.4 Political Issues
9.3.4.1 How Will Regulatory Developments Affect CMOs?
9.4 Trends in Drug Development Affecting CMOs to 2027
9.4.1 Orphan Drug Development: Smaller Manufacturing Capacities
9.4.2 Complex Biologics: Interest in ADCs is Increasing
9.4.3 How Will Biosimilar Market Growth Affect CMOs?
9.4.4 The Future of Small Molecule Outsourcing
9.5 How Will CMOs Expand in the Coming 10 Years?
9.5.1 CMO Consolidation Will Increase
9.5.2 There Will Be More Manufacturing Facilities Available for Acquisition
9.6 Developments in the Manufacturing Process 2016-2027
9.6.1 Rising Interest from Companies in Quality by Design (QbD)
9.6.2 A Move Towards Continuous Manufacturing

10. Pharmaceutical Contract Manufacturing Trends: Qualitative Analysis of the Pharmaceutical Contract Manufacturing Market from a Client Perspective 2016-2027
10.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a Client Perspective 2016-2027
10.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a Client Perspective 2016-2027
10.3 Important Aspects of the Outsourcing Decision
10.3.1 What Factors Will Influence CMO Selection?
10.3.2 CMO-Pharma Partnering Models
10.3.3 Strategic Partnering
10.3.4 Selecting a Local CMO vs. Offshoring
10.3.5 CMOs in Emerging Markets
10.3.6 Good Communication is Vital for Success
10.3.7 Ensuring Protection in Intellectual Property and Tech Transfer
10.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients
10.3.8.1 Regulatory Bodies and Outsourcing
10.3.8.2 Quality Agreement
10.3.8.3 Global Harmonisation Will Improve Compliance
10.4 Trends in Outsourcing Partnerships 2016-2027
10.4.1 Big Pharma and Outsourced Manufacturing
10.4.2 Small and Virtual Pharma Companies
10.4.3 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2027?

11. Conclusions
11.1 The World Pharmaceutical Contract Manufacturing Market
11.2 Outlook for the Market to 2027
11.2.1 Rising Demand for High Value Services 2016-2027
11.2.2 Demand Will Be Highest Among Developed-Market Clients
11.3 Which New Technologies Will Stimulate Demand to 2027?

Appendices
Visiongain’s Bespoke Research Service
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form

List of Tables
Table 1.1 Pharmaceutical Contract Manufacturing Market: Overall Market and Revenue Forecasts by Sector ($bn), 2015-2027
Table 1.2 Currency Exchange Rates
Table 3.1 Pharma Contract Manufacturing World Market Revenue ($bn), Annual Growth (%), CAGR (%), 2012-2016
Table 3.2 Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Sector, 2016
Table 3.3 Pharmaceutical Contract Manufacturing Market: Overall Market Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 3.4 Pharma Contract Manufacturing Market: Submarket Shares (%), 2014-2020
Table 3.5 Pharma Contract Manufacturing Market: Submarket Shares (%), 2021-2027
Table 3.6 Other Services Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 4.1 Contract API Manufacturing Submarket Revenue ($bn), Annual Growth (%), CAGR (%), 2012-2016
Table 4.2 Contract API Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2016
Table 4.3 Contract API Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 4.4 Contract API Manufacturing Submarket Shares (%), 2014-2020
Table 4.5 Contract API Manufacturing Submarket Shares (%), 2021-2027
Table 4.6 Contract API Manufacturing Submarket: Drivers and Restraints, 2016-2027
Table 4.7 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 4.8 Contract Generic API Manufacturing Submarket: Drivers and Restraints, 2016-2027
Table 4.9 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 4.10 Contract HPAPI Manufacturing Submarket: Drivers and Restraints, 2016-2027
Table 5.1 Contract FDF Manufacturing Submarket Revenue ($bn), Annual Growth (%), 2012-2016
Table 5.2 Contract FDF Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2016
Table 5.3 Contract FDF Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2014-2020
Table 5.5 Contract FDF Manufacturing Submarket: Segment Shares (%), 2021-2027
Table 5.6 Contract FDF Manufacturing Submarket: Drivers and Restraints, 2016-2027
Table 5.7 Contract Solid Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2015-2027
Table 5.8 Contract Solid Dosage Manufacturing Submarket: Drivers and Restraints, 2016-2027
Table 5.9 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2015-2027
Table 5.10 Contract Injectable Dosage Manufacturing Submarket: Drivers and Restraints, 2016-2027
Table 5.11 Selected ADCs in Development, 2016
Table 5.12 Selected CMOs Investing in ADC Manufacturing Capacity, 2015
Table 6.1 Pharma Contract Manufacturing Market: Revenues ($bn) and Market Shares (%) by Region, 2016
Table 6.2 Pharma Contract Manufacturing Market: Regional Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.3 Pharmaceutical Contract Manufacturing Market: Developed-Market Shares (%), 2014-2020
Table 6.4 Pharmaceutical Contract Manufacturing Market: Developed-Market Shares (%), 2021-2027
Table 6.5 GDUFA: Annual Fees for Domestic and Foreign Manufacturing Sites, 2015-2016
Table 6.6 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.7 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2014
Table 6.8 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2015
Table 6.9 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2016
Table 6.10 EU5 Pharma Contract Manufacturing Market: National Market Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.11 German Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.12 Selected French Manufacturing Site Acquisitions, 2009-2013
Table 6.13 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.14 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.15 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.16 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 6.17 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 7.1 Pharma Contract Manufacturing Market: Emerging Market Revenue ($bn) and Market Share (%) by Top Country, 2016
Table 7.2 Pharma Contract Manufacturing Market: Leading Emerging Market Forecasts ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 7.3 Pharma Contract Manufacturing Market: Emerging-Market Shares (%), 2014-2020
Table 7.4 Pharma Contract Manufacturing Market: Emerging-Market Shares (%), 2021-2027
Table 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 7.7 Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2015-2027
Table 8.1 Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Top Company, 2014
Table 8.2 Catalent: Revenue ($bn), Annual Growth (%), CAGR (%), 2010-2016
Table 8.3 Lonza Custom Manufacturing: Revenue ($bn), Annual Growth (%), CAGR (%), 2009-2015
Table 8.4 Lonza Custom Manufacturing: Revenue ($bn), Annual Growth (%), H1 2014-H1 2015
Table 8.5 DSP: Pharmaceutical Biotech Manufacturing Revenue ($bn), Annual Growth (%), CAGR (%), 2011-2014
Table 8.6 DPx and DSP: Q3 Revenue ($bn), 2014-2015
Table 8.7 Teva: Revenue ($bn), Annual Growth (%), CAGR (%), 2009-2015
Table 8.8 Teva API Revenue ($bn), Annual Growth (%), Q3 2014-Q3 2015
Table 8.9 Boehringer Ingelheim BioXcellence: Revenue ($bn), Annual Growth (%), CAGR (%), 2010-2015
Table 8.10 Famar: Revenue ($bn), Annual Growth (%), CAGR (%), 2011-2014
Table 9.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: CMO Perspective, 2016-2027
Table 9.2 Pharma Contract Manufacturing Market Opportunities and Threats: CMO Perspective, 2016-2027
Table 9.3 Pharma Contract Manufacturing Market: STEP Analysis, 2016-2027
Table 9.4 Selected Lyophilisation Service Providers, 2016
Table 9.5 Lyophilisation vs. Spray Drying: A Comparison, 2016
Table 9.6 Selected Orphan Drug Prices, 2014
Table 9.7 Selected Biological Manufacturing Expansion, 2011-2016
Table 9.8 Selected EU-Approved Biosimilars: Manufacturers and Companies, 2016
Table 9.9 Selected CMOs Growing Faster than the Market, 2007-2012
Table 9.10 Regional Market Expansion, 2010-2016
Table 10.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: Client Perspective, 2016-2027
Table 10.2 Pharma Contract Manufacturing Market Opportunities and Threats: Client Perspective, 2016-2027
Table 10.3 Benefits and Risks to Outsourcing Pharma Manufacturing, 2016
Table 10.4 ICH Guidelines: Key Facts and Adoption, 2000-2014
Table 12.1 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Sector, 2014, 2020 and 2027
Table 12.2 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Region, 2014, 2020 and 2027

List of Figures
Figure 1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation Overview, 2016
Figure 2.1 Selected Services Offered by CMOs, 2016
Figure 2.2 Major Trends Affecting Pharma Contract Manufacturing Revenue Growth, 2016-2027
Figure 3.1 Pharmaceutical Contract Manufacturing Market Revenue ($bn), 2012-2014
Figure 3.2 Pharmaceutical Contract Manufacturing Market Revenue ($bn), 2012-2016
Figure 3.3 Pharma Contract Manufacturing: Market Share (%) by Sector, 2016
Figure 3.4 Pharmaceutical Contract Manufacturing Market: Overall Market Forecast, Revenue ($bn), 2015-2027
Figure 3.5 Pharma Contract Manufacturing Market: Submarket Shares (%), 2020
Figure 3.6 Pharma Contract Manufacturing Market: Submarket Shares (%), 2027
Figure 3.7 Pharma Contract Manufacturing Market: Drivers, 2016-2027
Figure 3.8 Pharma Contract Manufacturing Market: Restraints, 2016-2027
Figure 3.9 Other Services Submarket Forecast, Revenue ($bn), 2015-2027
Figure 4.1 Contract API Manufacturing Submarket Revenue ($bn), 2012-2016
Figure 4.2 Contract API Manufacturing Submarket: Segment Shares (%) by Sector, 2016
Figure 4.3 Contract API Manufacturing Submarket Forecast, Revenue ($bn), 2015-2027
Figure 4.4 Contract API Manufacturing Submarket: Segment Shares (%), 2020
Figure 4.5 Contract API Manufacturing Submarket: Segment Shares (%), 2027
Figure 4.6 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), 2015-2027
Figure 4.7 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), 2015-2027
Figure 5.1 Contract FDF Manufacturing Submarket Revenue ($bn), 2012-2016
Figure 5.2 Contract FDF Manufacturing Submarket: Segment Shares (%) by Sector, 2016
Figure 5.3 Contract FDF Manufacturing Submarket Forecast, Revenue ($bn), 2015-2027
Figure 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2020
Figure 5.5 Contract FDF Manufacturing Submarket: Segment Shares (%), 2027
Figure 5.6 Contract Solid Dosage Manufacturing Submarket Forecast ($bn), 2015-2027
Figure 5.7 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), 2015-2027
Figure 6.1 Pharma Contract Manufacturing Market: Share (%) by Region, 2016
Figure 6.2 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2020
Figure 6.3 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2027
Figure 6.4 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 6.5 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2014
Figure 6.6 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2015
Figure 6.7 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2016
Figure 6.8 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2020
Figure 6.9 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2027
Figure 6.10 EU5 Pharma Contract Manufacturing Market: National Market Forecast, Revenue ($bn), 2015-2027
Figure 6.11 German Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 6.12 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 6.13 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 6.14 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 6.15 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 6.16 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 7.1 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2016
Figure 7.2 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2020
Figure 7.3 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2027
Figure 7.4Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2014, 2020 and 2027
Figure 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 7.7Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2015-2027
Figure 8.1 Pharma Contract Manufacturing: Market Share (%) by Top Company, 2014
Figure 8.2 Catalent: Revenue ($bn), 2010-2016
Figure 8.3 Lonza Custom Manufacturing: Revenue ($bn), 2009-2016
Figure 8.4 DSP: Pharmaceutical Biotech Manufacturing Revenue ($bn), 2011-2015
Figure 8.5 Teva: Revenue ($bn), 2009-2015
Figure 8.6 Boehringer Ingelheim BioXcellence: Revenue ($bn), 2010-2015
Figure 8.7 Famar: Revenue ($bn), 2011-2014
Figure 10.1 Overview of Approved ICH Manufacturing Guidelines, 2016
Figure 12.1 Pharma Contract Manufacturing Market: Revenue ($bn) by Sector, 2014, 2020 and 2027
Figure 12.2 Pharma Contract Manufacturing Market: Revenue ($bn) by Region, 2014, 2020 and 2027

【レポートのキーワード】

医薬品受託製造

★調査レポート[医薬品受託製造の世界市場2017-2027] ( Pharmaceutical Contract Manufacturing Market 2017-2027 / VGAIN702037) 販売に関する免責事項
[医薬品受託製造の世界市場2017-2027] ( Pharmaceutical Contract Manufacturing Market 2017-2027 / VGAIN702037) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆